TG

Tom Graney

CEO

NewCo - company in creation

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
NewCo - company in creation
Industry
biotechnology
Employees
35.0
Seniority
C suite
Annual Revenue
368000.0
Total Funding
48355000.0
Latest Funding
Series A

Technologies

Cloudflare DNS Outlook CloudFlare Hosting Hubspot WP Engine Viewpoint

Keywords

transmogrification direct cellular conversion stem cells cell therapy regenerative medicine drug discovery transcriptomics big data biotechnology bioinformatics machine learning transdifferentiation direct cellular reprogramming cell reprogramming gene therapy cell & gene therapy in vivo reprogramming cellular reprogramming in vivo therapies cell conversion technology epigenetic data transcription factors stem cell differentiation otology ophthalmology diabetes treatment unmet clinical needs big data approach gene regulatory networks computational modeling ex vivo therapies therapeutic cell types safety profiles clinical applications transcriptomic data platform technologies mogrify platform epimogrify platform target cell type generation cultural media conditions transcriptomic switches innovation in life sciences biotech investment direct cell reprogramming biomedical research collaborative partnerships cell identity maintenance pharmaceutical development gene editing technologies therapeutic interventions patient transformation clinical trials growth factors scientific collaboration biopharma industry healthcare innovations market potential venture capital research & development cellular biology advancements disruptive technology life science accelerator medical breakthroughs enterprise software enterprises computer software information technology & services b2b artificial intelligence health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans